Two Health Care Stocks Investors Should Hold
SINGAPORE – There are many portfolio monitors who will recommend that it is helpful to add a couple of safe stocks when making your stock investment and investment portfolio. A safe stock is one that can flourish even in currency downturns. Protection stocks not only provide security for your portfolio, but also work as a support in the midst of bear markets. The health care industry is considered a protective industry, as health care is a necessary part of everyday existence.
So having health care stocks to deal with your portfolio may be a smart idea. All things considered, there are two Singapore healthcare stocks that have a good growth rate.
ISEC Healthcare Ltd
International Specialist Eye Center (ISEC) is listed on SGX in 2014. The company is in Centrepoint South Mid Valley Kuala Lumpur, Penang Jalan Burma and Lee Hung Ming Eye Center are centers of excellence in ophthalmology, specifically in clinical care, teaching and research.
The group provides expert therapeutic ophthalmology benefits through its system of four eye centers in Malaysia and one at Gleneagles Hospital in Singapore. In 2016, the company expanded its administrations to incorporate general restorative administrations by obtaining JLM Companies, which contains four facilities in the heart of Singapore.
The system has worked admirably, so stock advice is to keep it in your portfolio. In 2017, the organization disclosed a 20% increase in revenue and a 22% increase in net profit. It also started 2018 well, with first-quarter revenue up 14%, while profit grew year-over-year.
This was attributed to a higher number of patients in their current centers, probably due to the extension of referrals of their recently obtained facility system.
The company has also said a couple of times that it plans to expand its territorial presence locally in China and Vietnam, where the market for eye administrations is considerably larger than Malaysia and Singapore.
With its perfect unencumbered asset report and S$27 million in real money, the organization surely has the budgetary power to make more acquisitions or establish a hub in its target markets. Labor income is expanding more reliably along with its net profit. This can provide the organization with the accounts to make further acquisitions or to reward investors through profits or offer buybacks.
Furthermore, at a cost of shares of S$0.29 (at compounding season), the organization is estimated at only 17.7 times its annualized profit and 2.23 times its book value. Above that, its offerings have a trailing earnings yield of 4.1%, the third-highest performance among human services stocks in Singapore.
Raffles Medical Group
Raffles Medical is the second largest healthcare administrator registered in Singapore. It owns a system of general practice facilities and a medical center in Singapore. The company has perhaps extraordinary compared to other development background in Singapore.
This Singapore stock selection started in 1976 with just two centers. Since then, the company has developed at a rapid pace and now has a network of centers located in Singapore and other countries such as China, Japan, Vietnam and Cambodia.
The company has also initiated plans for two new healing centers in China. They are a 700-bed medical center in Chongqing and a 400-bed healing center in Shanghai. It also added a 20-story expansion to its existing health center in Singapore in January this year, increasing its professional services and expanding its bed cap and facility space.
Surprisingly, Raffles Medical Equity has achieved this great development for the most part through their money earned from assignments. In 2017, the organization produced around S$83 million in income from work.
Despite the huge investments required for the two new healing centers, Raffles Medical, as of March 31, 2018, used only S$72 million of liability and accumulated S$94 million, giving it a net monetary position of S$22 million.
Would-be financial specialists should also be pleased to learn that the company’s Singapore stock trading has taken a significant beating in the market over the past few years. Deals are listed at just S$1.01 a piece, almost 30% below their peak. Market members have been concerned about the main concern stalling growth for the past few years due to market immersion in its core market in Singapore.
Raffles Medical shares as of now have a P/E ratio of 25.2, a P/B ratio of 2.4 and a return of 2.2%. These are attractive valuations, and long-term investors who will take care of any dental issues at their new healing facility will likely be compensated.
I hope you found this stock update article helpful. Stay up-to-date with our Singapore stocks blog for the best Singapore stock trading and investment signals.
Leave a comment in the comments section. Thank you!!